A study found that overexpression of ARST in glioma cells significantly suppressed cell growth, proliferation, migration, and invasion and reduced their tumorigenic capacity in vivo through interfering with actin cytoskeleton integrity (92). Here, LINC00632 is linked to central nervous system cancer.